Anti-CD52 Reference Antibody (gatralimab)
- Product Code: 139902
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used in the treatment of chronic lymphocytic leukemia (CLL) and other B-cell malignancies by targeting CD52, a protein highly expressed on the surface of malignant lymphocytes. It mediates cell lysis through complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity. Investigated for use in autoimmune disorders due to its ability to deplete lymphocytes, contributing to immune system modulation. Also serves as a reference standard in bioanalytical assays for evaluating biosimilars and immunoassay development.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50μg | 10-20 days | ฿4,980.00 |
+
-
|
Anti-CD52 Reference Antibody (gatralimab)
Used in the treatment of chronic lymphocytic leukemia (CLL) and other B-cell malignancies by targeting CD52, a protein highly expressed on the surface of malignant lymphocytes. It mediates cell lysis through complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity. Investigated for use in autoimmune disorders due to its ability to deplete lymphocytes, contributing to immune system modulation. Also serves as a reference standard in bioanalytical assays for evaluating biosimilars and immunoassay development.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :